Figure 7
The mechanism of zedoarondiol regulated HBSMCs proliferation. Working model depicting zedoarondiol promotes CAV-1 expression to regulate CAV-1-mediated negative regulation of proliferation signalling pathway, consequently inhibiting HBSMCs proliferation.
